PaLM Conf Minutes 2017-Apr-12

From IHE Wiki
Jump to navigation Jump to search

Back to IHE Pathology and Laboratory Medicine (PaLM) Domain

Back to IHE Pathology and Laboratory Medicine (PaLM)Technical Committee Page

Recording

The recording for this meeting can be downloaded [ HERE]

Attendees

Francois Macary, Co-Chair Phast
Riki Merrick, Co-Chair APHL
Carolyn Knapik CAP, secretariat
Alessandro Sulis CRS4
Dan Rutz Epic
Ed Heierman Abbott
Filip Migom MIPS
Francesca Frexia CRS4
Gunter Haroske IHE Germany
James Wulkan Beckman/Coulter
JD Nolen Cerner
Jessica Poisson Duke
Jurgen De Decker MIPS

Minutes

  • 1st hour
    • Agenda review
    • May F2F agenda (Francois, Riki)- Current F2F agenda items:
      • Held at JAHIS – address and hotels have been shared
      • SET (Alessandro will be remote, move to afternoons)
      • LCC (Riki in person, move to early in the day) – goal to get to ready for publishing for Public Comment
      • LSH (John)
      • APSR 2.0 (Gunter will be remote, so move to afternoons)
      • White paper (Raj in person)
      • New release of TF based on CPs (just a few) – to be published in June 2017 (Francois in person) – just 3 CPs, mostly from LAW update – (Ed not in person, so adjust time, if not covered by Francois), want to ballot before the meeting – start ballot 4/25 – Ed to prepare by then
      • Digital Pathology workflow – Raj will reach out to at least get a status update (Raj in person, move to early in the day)
      • Around the world updates (in PM)
      • Improve worldwide marketing – learn from Japan’s efforts
      • Transfusion medicine workflow (Dan / Jessica will be remote (9 AM is good slot for him), Filip )
      • Remote participation will be provided by JAHIS using CAP GTM, with voice on IP
      • Current F2F agenda can be viewed here: http://wiki.ihe.net/index.php/PaLM_F2F_Agenda_2017-May
    • Next month’s call was scheduled during HL7 WGM – move to 5/17/2017
    • SNOMED CT free subsets for IHE (Francois)
      • Drafted starter set has been complemented since last month – please review and add on  https://docs.google.com/spreadsheets/d/1rONueGvi6pxO6CKHpad90n7zEBya0Gxz2FSTQt5ILhY/edit#gid=0
        • Use APSR 2.0 value sets to add  additional concept candidates -> Gunter
      • Is now on the agenda for the DCC – will be discussed again with the intent that every domain submits its own candidate content into this common spreadsheet
      • If you want to contribute to the spreadsheet, send email to Francois so he can invite you
  • 2nd hour
    • SET profile updates (Alessandro)
      • Shared last version of Vol 1 (includes biobank use case) just prior to Connetacthon
      • Please send updates and edits to Alessandro prior to F2F
      • Alessandro & Francesca will work on Volume 2 as preparation for F2F
        • Start with Specimen Dam – it is being balloted right now
        • Define the meta data and which elements will be mandatory vs preferred / conditional / optional
        • Including trigger events, value sets to describe the actions performed on the specimen
        • Specimen CMET is in current ballot – Lorraine shared with Francois
    • LSH updates (John) – not on
    • Other topics?
      • Connectathon update in Venice
        • Tested more for lab profiles – about 40 tests were performed J
        • LAW and LTW and XD-Lab (most popular) these are all part of regulatory European  eHealth interoperability framework
        • Will have complete update at F2F
      • Transfusion medicine
        • How to report reaction to blood transfusion – per standard it is in the product level in the BXA? segment
        • In patient care in practice this is not associated to single unit, it is documented at the encounter level NLY – considering HL7 CR for discussion
        • Need to document a specific event – do we need new full message, or a segment that can be added to existing messages after related segments
        • Look at what patient care has
        • Or use REL to link to product
        • This still needs more research
        • Can we use ORU message – it is an observation on the patient?
        • Possible – but what is the workflow associated with this?
        • Do not want to confuse this with other observations / results
        • Other example is blood type – ore closer related to patient and less changeable
        • Product level documentation probably came from blood suppliers

Next Meeting: 17 May 2017 at 8:00am (central)

Retrieved from "http://wiki.ihe.net/index.php?title=PaLM_Conf_Minutes_2017-Apr-12&oldid=101224"